Start the conversation
Best stocks to buy for the week ending July 4, 2014: Each week our experts dish out the latest profit plays and asset-protection moves for our Money Morning Members – all for free.
Last week, we covered a "catalyst" that could spark a share-price rally for what is already one of the best stocks to buy, three recommendations to take advantage of rising oil prices, how to cash in on the liquefied natural gas (LNG) boom, and a way to tap into big profits in an "other" bioscience niche that is less risky but highly lucrative.
Get these, plus the top healthcare picks, dividend stocks, and more, in the full list of our best stocks to buy now.
Add These Picks to Your "Stocks to Buy" List
- Money Morning Executive Editor William Patalon III loves the General Electric Co. (NYSE: GE) investment story, and he's been following it for months. Last week, Patalon highlighted some recent big news for the tech company – at the end of June, the French government finally backed GE's $17 billion offer for the power and electrical-grid businesses of Alstom SA (OTCMKTS ADR: ALSMY). This is only one of a few exciting developments that are about to turn GE stock from a good investment into one of the true greats…
- With just six months left on Money Morning Bioscience Investment Specialist Ernie Tremblay's 2014 "profit calendar," things look very promising for bioscience investing in the second half of the year. For instance, the biologics subsector (compounds created naturally by living organisms and used as a different form of drugs) is growing fast. By 2016, biologics are predicted to account for 24% of sales in the world market – double their sales in 2004. And that's not the only market with strong growth this year. "The bioscience sector is healthy and full of potential for investors right now," Tremblay said – and he backed it up with tips for investors on how take advantage today of this sector's best opportunities…